PathAI Adds MET Predict to AISight for NSCLC Assessments
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read MorePosted by Andy Lundin | Sep 11, 2024 | Digital Pathology, Lung Cancer |
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read MorePosted by Andy Lundin | Aug 26, 2024 | Company News, Lung Cancer |
Summary: DELFI Diagnostics appointed Thomas Russo as its new CFO to support the company’s...
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read MorePosted by Andy Lundin | Jul 29, 2024 | Lung Cancer |
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read MorePosted by Chris Wolski | Jul 1, 2024 | Specimen Collection & Handling |
Ochsner Medical Center – Baton Rouge offers a robotic-assisted bronchoscopy using the Ion robotic platform.
Read More